2026 WHX Lagos & WHX Labs Lagos | Tap into West Africa and secure access to Africa’s largest healthcare market

June 2–4, 2026 The Nigeria International Medical Devices and Laboratory Equipment Exhibition, organized by Informa Markets, a globally renowned exhibition group, will be held in Lagos, a major commercial hub in West Africa. This edition of the show has been upgraded from two leading regional events—the Medic West Africa trade fair and Medlab West Africa—both of which are benchmarks in the West African healthcare sector. At its core, it hinges on “integration”: innovatively combining medical devices, laboratory technologies, digital health, and hospital management to create a healthcare ecosystem that spans the entire continuum—from diagnosis and treatment to rehabilitation. This is not merely a showcase; it is also a critical gateway for Chinese enterprises to penetrate Africa’s most populous country and secure a strategic foothold in the market. For exhibitors, this means gaining one‑stop, efficient access to decision‑makers across the entire value chain—hospital administrators, government officials, distributors, and clinical experts—in West Africa, thereby significantly expanding both the breadth and depth of their business partnerships.

📊 Significant internationalization of exhibitors: From around the world 20 countries and regions Over 500 companies Companies from around the world gathered in Lagos, with more than 90 Chinese exhibitors showcasing a total exhibition space exceeding 1,000 square meters.

👤 High quality and high quantity of the audience: It attracted more than 8,000 industry professionals, including healthcare administrators, technical experts, and procurement decision-makers.

⏩︎ The forum excels in professional depth: During the exhibition, more than 40 high‑quality, specialized forums were successfully held, bringing together over 1,500 attendees and more than 100 leading industry speakers.

Africa’s most populous country is driving sustained, essential demand for healthcare: Nigeria is Africa’s undisputed demographic powerhouse. According to the World Bank’s latest data, its total population has surpassed 219 million and continues to grow at an annual rate of approximately 2.5%, with projections indicating that it will become the world’s third-largest country by population by 2050. A large and youthful demographic structure underpins the long-term growth of the healthcare market and provides a solid foundation of rigid demand.

Over 95% relies on imports, and the domestic manufacturing base is weak: In sharp contrast to the enormous demand is its weak medical-industrial system. More than 95%, and in some cases as much as 99%, of the country’s medical device market is entirely reliant on imports, with domestic production limited to a small range of basic consumables. This exceptionally high degree of external dependence provides global suppliers—particularly Chinese companies that have already established a strong local reputation—with ample opportunities for market access.

A multi-billion-dollar market is expanding rapidly, with an annual growth rate exceeding 11%. The significant gap between local manufacturing capacity and healthcare demand is translating into quantifiable market opportunities. According to industry analysis, Nigeria’s medical device market is projected to grow from approximately USD 730 million in 2024 at a compound annual growth rate exceeding 11%, with the market size expected to surpass USD 1.15 billion by 2028. This growth encompasses the full spectrum of demand, from high-end imaging equipment to basic medical consumables, reflecting a broad and diversified market landscape.

“Import Substitution” and “Policy Dividends” Open a New Window: At present, the market is undergoing a pivotal transformation, presenting Chinese enterprises with profound opportunities that extend beyond mere product exports.

Import Substitution Window: In the face of currency volatility and supply-chain security concerns, the Nigerian government and the private sector are vigorously promoting “healthcare self-reliance,” with their core priorities shifting from simply “purchasing products” to seeking technology transfer, localized production, and long-term partnerships.

Clarify policy benefits: To effectively encourage domestic manufacturing, the President of Nigeria signed an executive order in June 2024 exempting raw materials and certain finished medical devices used in local production from import duties and taxes. This provides direct cost advantages to companies investing in Nigeria to establish factories or engage in knock-down assembly.

Booth reservations for the 2026 Nigeria International Medical Devices and Laboratory Instrument Exhibition are now fully underway. Given the limited number of exhibition booths and the strong demand seen at previous events, companies interested in participating are advised to act promptly to secure prime locations.